Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001421008 | SCV001623472 | benign | Hyper-IgE recurrent infection syndrome 4, autosomal recessive | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001522174 | SCV001731661 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV003490246 | SCV004234066 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001522174 | SCV005301099 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003983889 | SCV004799874 | benign | IL6ST-related disorder | 2019-11-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |